{"id":100167,"date":"2014-04-03T00:37:22","date_gmt":"2014-04-03T00:37:22","guid":{"rendered":"https:\/\/knome.com\/?p=100167"},"modified":"2024-09-12T13:40:32","modified_gmt":"2024-09-12T13:40:32","slug":"knome-appoints-hugh-y-rienhoff-jr-md-to-scientific-advisory-board","status":"publish","type":"post","link":"https:\/\/www.knome.com\/?p=100167","title":{"rendered":"Knome Appoints Hugh Y. Rienhoff, Jr., MD to Scientific Advisory Board"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;section&#8221; _builder_version=&#8221;4.27.0&#8243; custom_margin=&#8221;0px||0px||false|false&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221; theme_builder_area=&#8221;post_content&#8221;][et_pb_row admin_label=&#8221;row&#8221; _builder_version=&#8221;4.16&#8243; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221; global_colors_info=&#8221;{}&#8221; theme_builder_area=&#8221;post_content&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221; theme_builder_area=&#8221;post_content&#8221;][et_pb_heading title=&#8221;Knome Appoints Hugh Y. Rienhoff, Jr., MD to Scientific Advisory Board&#8221; _builder_version=&#8221;4.27.0&#8243; _module_preset=&#8221;default&#8221; title_text_color=&#8221;#E02B20&#8243; title_font_size=&#8221;25px&#8221; custom_margin=&#8221;0px||0px||false|false&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; theme_builder_area=&#8221;post_content&#8221; sticky_enabled=&#8221;0&#8243;][\/et_pb_heading][et_pb_text admin_label=&#8221;Text&#8221; _builder_version=&#8221;4.27.0&#8243; text_font_size=&#8221;14px&#8221; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; theme_builder_area=&#8221;post_content&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<p><strong><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.knome.com\/wp-content\/uploads\/2024\/09\/RienhoffFeature-2we28h2tglmhlb2zb6rk00.jpg\" width=\"249\" height=\"250\" alt=\"\" class=\"wp-image-100168 alignnone size-full\" style=\"float: left;\" srcset=\"https:\/\/www.knome.com\/wp-content\/uploads\/2024\/09\/RienhoffFeature-2we28h2tglmhlb2zb6rk00.jpg 249w, https:\/\/www.knome.com\/wp-content\/uploads\/2024\/09\/RienhoffFeature-2we28h2tglmhlb2zb6rk00-150x150.jpg 150w\" sizes=\"(max-width: 249px) 100vw, 249px\" \/>Dr. Rienhoff brings deep industry and technical expertise as Knome continues to expand<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>CAMBRIDGE, MA \u2013 April 3, 2012 \u2013 Knome, Inc., the human genome interpretation company, today announced that it has continued to expand its scientific advisory board to include respected life sciences expert and industry pioneer, Hugh Y. Rienhoff, Jr., MD.<\/p>\n<p>\u201cWe are very pleased to appoint Dr. Rienhoff to our scientific advisory board,\u201d said Martin Tolar, MD, PhD, Chief Executive Officer of Knome. \u201cDr. Rienhoff brings a unique, diverse, and deeply entrepreneurial perspective that will further strengthen our scientific advisory board as we pursue new drug development and clinical applications of Knome\u2019s technology. We look forward to benefiting from the depth and breadth of his insights.\u201d<\/p>\n<p>Dr. Rienhoff has more than 20 years of experience as a technology visionary, entrepreneur, and venture investor in life sciences. He is currently a Managing Director of Life Science Venture Partners and serves as an Adjunct Scientist at the Children\u2019s Hospital Oakland Research Institute. In the field of genomics, Dr. Rienhoff is known for the founding of the nonprofit organization MyDaughtersDNA.org, a community focused on aiding those with challenging genetic conditions. He presently serves as Chief Executive Officer at FerroKin BioSciences, a company he founded as part of his ongoing interest in the treatment of rare disorders. Previously, Dr. Rienhoff served as Chief Executive Officer and Chairman of the Board of DNA Sciences, Inc., a privately held biotechnology company he founded in 1998 (formerly Kiva Genetics, Inc.). He was also a founding director of Healtheon Corporation, a health-focused Internet portal now widely known as WebMD Health.<\/p>\n<p>\u201cKnome brings together the team, technology, and application focus needed to bring genomics into the practice of medicine\u2014and ultimately the lives of patients. This is a pivotal time for Knome: rendering genomic data manageable and actionable to a broad array of users will drive Knome\u2019s ultimate success in addressing the dynamic needs of key markets. I am excited to join the Knome advisory team and look forward to helping Knome maintain its leadership position in the application of human genomic information,\u201d said Dr. Rienhoff.<\/p>\n<p>Dr. Rienhoff previously has served as a General Partner of Vanguard Ventures and as a Partner of New Enterprise Associates. Dr. Rienhoff was a member of the faculty in the Department of Molecular Biology and Genetics at The Johns Hopkins University School of Medicine. He trained in mathematics, medicine, and genetics at Harvard University, Johns Hopkins University, and the Fred Hutchinson Cancer Research Center in Seattle, Washington, and received an MD from The Johns Hopkins University School of Medicine.<\/p>\n<p>Knome\u2019s scientific advisory board is chaired by George Church, PhD, Professor of Genetics at Harvard Medical School, Director of the Harvard-Lipper Center for Computational Genetics, and cofounder of Knome. Other members of the board include Lincoln Stein, MD, PhD, Professor at Cold Spring Harbor Laboratory and Platform Leader of Informatics and Biocomputing at the Ontario Institute for Cancer Research; David Goldstein, PhD, Professor of Molecular Genetics &amp; Microbiology, Professor of Biology, and Director of the Center for Human Genome Variation at Duke University; Yaniv Erlich, PhD, the Andria and Paul Heafy Family Fellow and Principal Investigator at the Whitehead Institute for Biomedical Research at the Massachusetts Institute of Technology; and Anthony Sinskey, ScD, Professor of Microbiology and Health Sciences and Technology at the Massachusetts Institute of Technology.<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=&#8221;4.27.0&#8243; _module_preset=&#8221;default&#8221; text_font_size=&#8221;13px&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; theme_builder_area=&#8221;post_content&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<p><strong>About Knome<\/strong><br \/><span>Knome is a life sciences company that specializes in the interpretation of human genomes. Knome provides tools and solutions that help researchers, drug developers, and clinicians determine the genetic basis of human disease and drug response. In 2008, Knome had the distinction of being the first company to interpret a human whole genome for a commercial client. Since then, Knome has worked on over 100 interpretation projects in more than two dozen countries.<\/span><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dr. Rienhoff brings deep industry and technical expertise as Knome continues to expand &nbsp; CAMBRIDGE, MA \u2013 April 3, 2012 \u2013 Knome, Inc., the human genome interpretation company, today announced that it has continued to expand its scientific advisory board to include respected life sciences expert and industry pioneer, Hugh Y. Rienhoff, Jr., MD. \u201cWe [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":100168,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"<img class=\"size-full wp-image-100015 alignleft\" src=\"https:\/\/www.knome.com\/wp-content\/uploads\/2024\/09\/GENALICE.jpg\" alt=\"\" width=\"300\" height=\"70\" \/>\r\n\r\nHARDERWIJK, the Netherlands and CAMBRIDGE, Mass \u2013 January 12, 2015 \u2013 Today GENALICE and Knome, Inc. USA jointly announced a strategic partnership to offer their products together as a turn-key solution for those using next-generation sequencing (NGS) data to interpret patients\u2019 genomes. GENALICE MAP is an ultra-fast and highly accurate preprocessing solution for aligning and calling NGS data and seamlessly connects to Knome\u2019s informatics and genomics interpretation system, the knoSYS<sup>\u00ae<\/sup>\u00a0platform.\r\n\r\nStated CEO and President of Knome, Wolfgang Daum, \u201cThe GENALICE and Knome partnership came about in response to the reality that the amount of NGS data and its increasing usage requires processing and interpreting at an incredible pace. Wide-spread implementation of sequencing in the clinic toward the goal of precision medicine will only make this fact more apparent.\u201d\r\n\r\nWhile both products will continue to be offered separately, customers wanting to take advantage of the combined system can expect a reduction of NGS data bottlenecks, improved ability to annotate and interpret human genomes, and unprecedented control over their data from end-to-end.\r\n\r\nHans Karten, CEO of GENALICE, commented, \u201cWhereas GENALICE MAP speeds up and improves the process of aligning and calling genomes, the knoSYS platform focuses on the annotation and interpretation piece. These two products complement each other beautifully in creating a workflow that eliminates many of the frustrations of wrangling NGS data today.\u201d\r\n\r\n<strong>About Knome, Inc.<\/strong>\r\nKnome, Inc. is a leading provider of human genome interpretation systems and services. Knome provides tools and solutions that help researchers, drug developers, and clinicians determine the genetic basis of human disease and drug response. Designed to accelerate and industrialize the process of interpreting whole genomes, Knome\u2019s big data technologies are helping to smooth the healthcare industry\u2019s transition to molecular-based, precision medicine.\r\n\r\n<strong>About GENALICE<\/strong>\r\nGENALICE is a highly innovative biomedical big data company, with global headquarters in the Netherlands. GENALICE designs and builds groundbreaking software solutions for ultra-fast, highly accurate and cost-effective DNA data processing and analysis on general-purpose hardware. With GENALICE MAP, it introduced the first Next-Generation Sequencing (NGS) data processing pipeline with true population power. By partnering with world-renowned research institutes and healthcare companies, GENALICE is committed to unlocking the potential of whole genome and exome sequencing for biomarker discovery and medical application. More information on GENALICE can be found at\u00a0<a href=\"http:\/\/www.genalice.com\/\" target=\"_blank\" rel=\"noopener\">www.genalice.com<\/a>.\r\n\r\n<strong>Media Contacts<\/strong>\r\n<div>Knome, Inc. USA\r\nJessica Vionas\r\nDirector of Marketing\r\n617-715-1000 x2012\r\njvionas@knome.com<\/div>\r\n<div>GENALICE B.V.\r\nJos Lunenberg\r\nChief Business Officer\r\n+31 88 1221 000\r\njos.lunenberg@genalice.com<\/div>\r\n<p align=\"center\">###<\/p>\r\n<p align=\"center\"><\/p>","_et_gb_content_width":"","footnotes":""},"categories":[1],"tags":[],"class_list":["post-100167","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-press-releases"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Knome Appoints Hugh Reinhoff to Scientific Advisory Board<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.knome.com\/?p=100167\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Knome Appoints Hugh Reinhoff to Scientific Advisory Board\" \/>\n<meta property=\"og:description\" content=\"Dr. Rienhoff brings deep industry and technical expertise as Knome continues to expand &nbsp; CAMBRIDGE, MA \u2013 April 3, 2012 \u2013 Knome, Inc., the human genome interpretation company, today announced that it has continued to expand its scientific advisory board to include respected life sciences expert and industry pioneer, Hugh Y. Rienhoff, Jr., MD. \u201cWe [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.knome.com\/?p=100167\" \/>\n<meta property=\"og:site_name\" content=\"Knome | Genome Interpretation Systems &amp; Services\" \/>\n<meta property=\"article:published_time\" content=\"2014-04-03T00:37:22+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-12T13:40:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.knome.com\/wp-content\/uploads\/2024\/09\/RienhoffFeature-2we28h2tglmhlb2zb6rk00.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"249\" \/>\n\t<meta property=\"og:image:height\" content=\"250\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Jason Bailey\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jason Bailey\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.knome.com\\\/?p=100167#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.knome.com\\\/?p=100167\"},\"author\":{\"name\":\"Jason Bailey\",\"@id\":\"https:\\\/\\\/www.knome.com\\\/#\\\/schema\\\/person\\\/eb7b08ce3aec9801f4fc316c4122bed3\"},\"headline\":\"Knome Appoints Hugh Y. Rienhoff, Jr., MD to Scientific Advisory Board\",\"datePublished\":\"2014-04-03T00:37:22+00:00\",\"dateModified\":\"2024-09-12T13:40:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.knome.com\\\/?p=100167\"},\"wordCount\":844,\"image\":{\"@id\":\"https:\\\/\\\/www.knome.com\\\/?p=100167#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.knome.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/RienhoffFeature-2we28h2tglmhlb2zb6rk00.jpg\",\"articleSection\":[\"Press Releases\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.knome.com\\\/?p=100167\",\"url\":\"https:\\\/\\\/www.knome.com\\\/?p=100167\",\"name\":\"Knome Appoints Hugh Reinhoff to Scientific Advisory Board\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.knome.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.knome.com\\\/?p=100167#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.knome.com\\\/?p=100167#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.knome.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/RienhoffFeature-2we28h2tglmhlb2zb6rk00.jpg\",\"datePublished\":\"2014-04-03T00:37:22+00:00\",\"dateModified\":\"2024-09-12T13:40:32+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.knome.com\\\/#\\\/schema\\\/person\\\/eb7b08ce3aec9801f4fc316c4122bed3\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.knome.com\\\/?p=100167#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.knome.com\\\/?p=100167\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.knome.com\\\/?p=100167#primaryimage\",\"url\":\"https:\\\/\\\/www.knome.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/RienhoffFeature-2we28h2tglmhlb2zb6rk00.jpg\",\"contentUrl\":\"https:\\\/\\\/www.knome.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/RienhoffFeature-2we28h2tglmhlb2zb6rk00.jpg\",\"width\":249,\"height\":250},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.knome.com\\\/?p=100167#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.knome.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Knome Appoints Hugh Y. Rienhoff, Jr., MD to Scientific Advisory Board\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.knome.com\\\/#website\",\"url\":\"https:\\\/\\\/www.knome.com\\\/\",\"name\":\"Knome | Genome Interpretation Systems &amp; Services\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.knome.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.knome.com\\\/#\\\/schema\\\/person\\\/eb7b08ce3aec9801f4fc316c4122bed3\",\"name\":\"Jason Bailey\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/56bce6b92ef218a6b47a057c253c7c75450a6bb5a6b3e61df84aa47d5443f933?s=96&d=wavatar&r=x\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/56bce6b92ef218a6b47a057c253c7c75450a6bb5a6b3e61df84aa47d5443f933?s=96&d=wavatar&r=x\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/56bce6b92ef218a6b47a057c253c7c75450a6bb5a6b3e61df84aa47d5443f933?s=96&d=wavatar&r=x\",\"caption\":\"Jason Bailey\"},\"url\":\"https:\\\/\\\/www.knome.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Knome Appoints Hugh Reinhoff to Scientific Advisory Board","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.knome.com\/?p=100167","og_locale":"en_US","og_type":"article","og_title":"Knome Appoints Hugh Reinhoff to Scientific Advisory Board","og_description":"Dr. Rienhoff brings deep industry and technical expertise as Knome continues to expand &nbsp; CAMBRIDGE, MA \u2013 April 3, 2012 \u2013 Knome, Inc., the human genome interpretation company, today announced that it has continued to expand its scientific advisory board to include respected life sciences expert and industry pioneer, Hugh Y. Rienhoff, Jr., MD. \u201cWe [&hellip;]","og_url":"https:\/\/www.knome.com\/?p=100167","og_site_name":"Knome | Genome Interpretation Systems &amp; Services","article_published_time":"2014-04-03T00:37:22+00:00","article_modified_time":"2024-09-12T13:40:32+00:00","og_image":[{"width":249,"height":250,"url":"https:\/\/www.knome.com\/wp-content\/uploads\/2024\/09\/RienhoffFeature-2we28h2tglmhlb2zb6rk00.jpg","type":"image\/jpeg"}],"author":"Jason Bailey","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Jason Bailey","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.knome.com\/?p=100167#article","isPartOf":{"@id":"https:\/\/www.knome.com\/?p=100167"},"author":{"name":"Jason Bailey","@id":"https:\/\/www.knome.com\/#\/schema\/person\/eb7b08ce3aec9801f4fc316c4122bed3"},"headline":"Knome Appoints Hugh Y. Rienhoff, Jr., MD to Scientific Advisory Board","datePublished":"2014-04-03T00:37:22+00:00","dateModified":"2024-09-12T13:40:32+00:00","mainEntityOfPage":{"@id":"https:\/\/www.knome.com\/?p=100167"},"wordCount":844,"image":{"@id":"https:\/\/www.knome.com\/?p=100167#primaryimage"},"thumbnailUrl":"https:\/\/www.knome.com\/wp-content\/uploads\/2024\/09\/RienhoffFeature-2we28h2tglmhlb2zb6rk00.jpg","articleSection":["Press Releases"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.knome.com\/?p=100167","url":"https:\/\/www.knome.com\/?p=100167","name":"Knome Appoints Hugh Reinhoff to Scientific Advisory Board","isPartOf":{"@id":"https:\/\/www.knome.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.knome.com\/?p=100167#primaryimage"},"image":{"@id":"https:\/\/www.knome.com\/?p=100167#primaryimage"},"thumbnailUrl":"https:\/\/www.knome.com\/wp-content\/uploads\/2024\/09\/RienhoffFeature-2we28h2tglmhlb2zb6rk00.jpg","datePublished":"2014-04-03T00:37:22+00:00","dateModified":"2024-09-12T13:40:32+00:00","author":{"@id":"https:\/\/www.knome.com\/#\/schema\/person\/eb7b08ce3aec9801f4fc316c4122bed3"},"breadcrumb":{"@id":"https:\/\/www.knome.com\/?p=100167#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.knome.com\/?p=100167"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.knome.com\/?p=100167#primaryimage","url":"https:\/\/www.knome.com\/wp-content\/uploads\/2024\/09\/RienhoffFeature-2we28h2tglmhlb2zb6rk00.jpg","contentUrl":"https:\/\/www.knome.com\/wp-content\/uploads\/2024\/09\/RienhoffFeature-2we28h2tglmhlb2zb6rk00.jpg","width":249,"height":250},{"@type":"BreadcrumbList","@id":"https:\/\/www.knome.com\/?p=100167#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.knome.com\/"},{"@type":"ListItem","position":2,"name":"Knome Appoints Hugh Y. Rienhoff, Jr., MD to Scientific Advisory Board"}]},{"@type":"WebSite","@id":"https:\/\/www.knome.com\/#website","url":"https:\/\/www.knome.com\/","name":"Knome | Genome Interpretation Systems &amp; Services","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.knome.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.knome.com\/#\/schema\/person\/eb7b08ce3aec9801f4fc316c4122bed3","name":"Jason Bailey","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/56bce6b92ef218a6b47a057c253c7c75450a6bb5a6b3e61df84aa47d5443f933?s=96&d=wavatar&r=x","url":"https:\/\/secure.gravatar.com\/avatar\/56bce6b92ef218a6b47a057c253c7c75450a6bb5a6b3e61df84aa47d5443f933?s=96&d=wavatar&r=x","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/56bce6b92ef218a6b47a057c253c7c75450a6bb5a6b3e61df84aa47d5443f933?s=96&d=wavatar&r=x","caption":"Jason Bailey"},"url":"https:\/\/www.knome.com\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/www.knome.com\/index.php?rest_route=\/wp\/v2\/posts\/100167","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.knome.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.knome.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.knome.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.knome.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=100167"}],"version-history":[{"count":3,"href":"https:\/\/www.knome.com\/index.php?rest_route=\/wp\/v2\/posts\/100167\/revisions"}],"predecessor-version":[{"id":100171,"href":"https:\/\/www.knome.com\/index.php?rest_route=\/wp\/v2\/posts\/100167\/revisions\/100171"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.knome.com\/index.php?rest_route=\/wp\/v2\/media\/100168"}],"wp:attachment":[{"href":"https:\/\/www.knome.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=100167"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.knome.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=100167"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.knome.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=100167"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}